Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial
- 1 November 2010
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 376 (9753) , 1682-1688
- https://doi.org/10.1016/s0140-6736(10)61230-5
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Effectiveness of Immunization against Paralytic Poliomyelitis in NigeriaNew England Journal of Medicine, 2008
- Monovalent Type 1 Oral Poliovirus Vaccine in NewbornsNew England Journal of Medicine, 2008
- Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control studyThe Lancet, 2007
- New Strategies for the Elimination of Polio from IndiaScience, 2006
- Sabin Monovalent Oral Polio Vaccines: Review of Past Experiences and Their Potential Use after Polio EradicationClinical Infectious Diseases, 2001
- Seroresponse to trivalent oral poliovirus vaccine as a function of dosage intervalThe Pediatric Infectious Disease Journal, 1995
- RANDOMISED TRIAL OF ALTERNATIVE FORMULATIONS OF ORAL POLIOVACCINE IN BRAZILThe Lancet, 1988